Biomarker for Outcome Prediction in Neonates with Congenital Diaphragmatic Hernia

Recruiting

• Conditions: Q79.0; Z38.0; Singleton, born in hospital; Congenital diaphragmatic hernia

• Registration Number: DRKS00034329
• Lead Sponsor: niversitätsklinikum Bonn, Klinik für Neonatologie und Pädiatrische Intensivmedizin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-05-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

diagnosis of congenital diaphragmatic hernia

Exclusion Criteria

Neonates received planned palliative care,
CDH with concomitant congenital heart defect.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the composite endpoint of bronchopulmonary dysplasia or death. Bronchopulmonary dysplasia is defined as oxygen requirement beyond the 28th day of life. The combined endpoint includes newborns who died by 28 days of life.